Methods and devices for paranasal sinus drug delivery
US-9333327-B2 · May 10, 2016 · US
US11724074B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11724074-B2 |
| Application number | US-202017081548-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 27, 2020 |
| Priority date | Apr 24, 2009 |
| Publication date | Aug 15, 2023 |
| Grant date | Aug 15, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are methods and devices for delivering a drug to the frontal sinus system. An inflatable implant is positioned within the frontal sinus system using an anchoring means secured within the frontal sinus cavity. A drug-containing fluid is released directly into the frontal sinus drainage system.
Opening claim text (preview).
The invention claimed is: 1. A drug delivery system, comprising: an elongated shaft comprising an outer tube and an inner tube, wherein the inner tube is disposed in a first lumen of the outer tube, wherein the inner tube defines a second lumen; a fluid reservoir in fluid communication with the inner tube via a flow port in the inner tube, wherein the fluid reservoir is further in fluid communication with the first lumen of the outer tube via a gap between the inner tube and the outer tube; and a dispensing structure on the outer tube, wherein the dispensing structure is configured to dispense a fluid to a drainage pathway of a frontal sinus cavity; and an anchoring structure configured to engage the frontal sinus cavity such that the dispensing structure is located in the drainage pathway of the frontal sinus cavity, wherein the inner tube, the fluid reservoir, the outer tube, and the dispensing structure define a fluid pathway such that the fluid flows (i) distally along the second lumen of the inner tube, (ii) from the second lumen of the inner tube to the fluid reservoir via the flow port, (iii) from the fluid reservoir to the first lumen of the outer tube via the gap between the inner tube and the outer tube, (iv) proximally along the first lumen of the outer tube to the dispensing structure, and (v) through the dispensing structure to the drainage pathway of the frontal sinus cavity. 2. The drug delivery system of claim 1 , wherein the fluid reservoir has a proximal end and a distal end, wherein the inner tube extends through the proximal end of the fluid reservoir to the distal end of the fluid reservoir. 3. The drug delivery system of claim 2 , the proximal end of the fluid reservoir is coupled to outer tube. 4. The drug delivery system of claim 3 , the distal end of the fluid reservoir is coupled to inner tube. 5. The drug delivery system of claim 2 , wherein the fluid reservoir is an inflatable balloon. 6. The drug delivery system of claim 5 , wherein the inflatable balloon comprises a plurality of lobes. 7. The drug delivery system of claim 2 , wherein the fluid reservoir is a rigid container. 8. The drug delivery system of claim 1 , further comprising a one-way valve in the second lumen of the inner tube, wherein the one-way valve is located proximal of the flow port. 9. The drug delivery system of claim 1 , wherein the dispensing structure comprises a plurality of ports along the outer tube. 10. The drug delivery system of claim 9 , wherein the plurality of ports along the outer tube are disposed along a central axis of the elongated shaft, wherein the central axis is in a direction between a proximal end of the elongated shaft and a distal end of the elongated shaft. 11. The drug delivery system of claim 1 , further comprising a cap at a distal end of the inner tube, wherein the cap is configured to assist in directing the fluid from the second lumen of the inner tube to the flow port. 12. The drug delivery system of claim 1 , wherein the outer tube is sealed to the inner tube a location that is proximal of the dispensing structure such that fluid is prevented from flowing along the first lumen proximally past the location at which the outer tube is sealed to the inner tube. 13. The drug delivery system of claim 12 , further comprising a washer positioned between the inner tube and the outer tube at the location that is proximal of the dispensing structure, and wherein the washer is configured to seal the outer tube to the inner tube. 14. The drug delivery system of claim 1 , wherein the anchoring structure coupled to the elongated shaft at a location that is proximal of the fluid reservoir. 15. The drug delivery system of claim 14 , wherein the anchoring structure comprises plurality of retention wings. 16. The drug delivery system of claim 15 , wherein an outer diameter of the plurality of the anchor structure is configured to expand, relative to a central axis of the elongated shaft, from a first diameter to a second diameter. 17. The drug delivery system of claim 1 , wherein the fluid comprise a pharmaceutical agent. 18. The drug delivery system of claim 1 , further comprising a sheath comprising a third lumen, wherein at least a portion of the elongated shaft is disposed in the third lumen of the sheath, wherein the sheath is movable between a distal position on the elongated shaft and a proximal position on the elongated shaft, and wherein the anchor structure is contained within the third lumen of the sheath when the sheath is in the distal position. 19. The drug delivery system of claim 18 , wherein the anchor structure is expandable responsive to the sheath moving from the distal position to the proximal position. 20. The drug delivery system of claim 18 , wherein the fluid reservoir is contained within the third lumen of the sheath when the sheath is in the distal position, and the fluid reservoir is configured to expand when the sheath is in the proximal position. 21. The drug delivery system of claim 1 , wherein the inner tube extends distally of a distal end of the outer tube. 22. The drug delivery system of claim 1 , wherein, along at least a portion of a length of the elongated shaft, an entire circumference of the inner tube is disposed radially inward of an entire circumference of the outer tube.
characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence) · CPC title
for use in the oral cavity, larynx, bronchial passages or nose (for medical inspection of cavities or tubes in the body A61B1/00); Tongue scrapers · CPC title
with embedded structures, e.g. coils, braids, meshes, strands or radiopaque coils · CPC title
Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202) · CPC title
Nose parts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.